Fei Xiao

9PUBLICATIONS
14CO-AUTHORS
Predictive and prognostic markersNutritional epidemiologyMedical infection agents (incl. prions)Veterinary virologyAutonomic nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 27, 2026
The epigenetic KMT5C-HDAC1 axis promotes hepatocellular carcinoma stemness and progression through SERPINA4 repression and chromatin compaction.

|Jun 26, 2026
PMVK drives hepatocarcinogenesis via SP1 phosphorylation-mediated lipid metabolic reprogramming.

|Nov 17, 2025
HERP constrains white adipose expansion and inflammation by STEAP4 stabilization.

Yingchun Chen, Yanyan Wu, Haorui Qin

|May 26, 2024
TMX2 potentiates cell viability of hepatocellular carcinoma by promoting autophagy and mitophagy.

Weiyu Zhang, Yao Tang, Pengfei Yang

|Oct 04, 2023
ATAD1 inhibits hepatitis C virus infection by removing the viral TA-protein NS5B from mitochondria.

Qing Zhou, Yuhao Yang, Zhanxue Xu

|Apr 01, 2022
SARS-CoV-2 spike spurs intestinal inflammation via VEGF production in enterocytes.

Fa-Min Zeng, Ying-Wen Li, Zhao-Hua Deng

Pageof 2

Frequent Collaborators

2 joint publications

Zhiju Zhao

2 joint publications

Qiuyan Wang

2 joint publications

Yingchun Chen

1 joint publications

Jun Li